{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:21:52Z","timestamp":1794360112758,"version":"4.9.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare of Japan","doi-asserted-by":"crossref","award":["KSat No. 14507303"],"award-info":[{"award-number":["KSat No. 14507303"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Committee of Prion Disease and Slow Virus Infection, Research on Policy Planning and Evaluation for Rare and Intractable Diseases, Health and Labour Sciences Research","award":["JPMH20FC1054"],"award-info":[{"award-number":["JPMH20FC1054"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["20ek0109362"],"award-info":[{"award-number":["20ek0109362"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Committee of Surveillance and Infection Control of Prion Disease, the Ministry of Health, Labour, and Welfare of Japan","award":["JPMH20FC2001"],"award-info":[{"award-number":["JPMH20FC2001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Invasive tests like cerebrospinal fluid (CSF) examination are highly effective for diagnosing human prion disease (HPD). Real-time quaking-induced conversion (RT-QuIC) CSF assay demonstrates 80\u201390% sensitivity for HPD diagnosis. To establish a minimally invasive diagnostic approach, we evaluated RT-QuIC testing on hair root and scalp samples. We collected scalp samples from 22 HPD and 5 non-HPD patients during pathological examinations and analyzed them using RT-QuIC assay and neuropathological methods. In our prospective study, hair root and CSF samples from 300 patients were tested using RT-QuIC assay along with other biomarkers, including 14-3-3 protein, total tau protein, RT-QuIC CSF assay, and MRI findings. All 22 HPD patients demonstrated positive prion seeding activity in scalp and hair root RT-QuIC assays. Neuropathological examination in one HPD patient revealed abnormal prion protein in scalp tissue. Among 177 HPD patients diagnosed by Japan Prion Surveillance Committee and 123 non-HPD patients, RT-QuIC assay of hair roots demonstrated sensitivity and specificity of 45.8% and 100%, respectively. Sensitivities of 14-3-3 protein, total tau protein, RT-QuIC CSF assay, and MRI findings were 83.1%, 86.4%, 74.6%, and 100%, respectively, with specificities of 65.0%, 65.0%, 100%, and 56.1%, respectively. RT-QuIC assays could be developed into novel diagnostic methods for neurodegenerative diseases.<\/jats:p>","DOI":"10.1038\/s41598-025-25310-y","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:28:40Z","timestamp":1763987320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A noninvasive test for human prion disease using hair roots and scalp"],"prefix":"10.1038","volume":"15","author":[{"given":"Thi-Thu-Trang","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitaru","family":"Kishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensaku","family":"Kasuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiro","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Ikenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ikeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Takiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Murota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Sanjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Kitayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Yukitake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuyuki","family":"Kitamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Takao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiro","family":"Mizusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"25310_CR1","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner, S. B. Prions. Proc. Natl Acad. Sci. USA 95, 13363\u201313383 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25310_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","volume":"46","author":"P Parchi","year":"1999","unstructured":"Parchi, P. et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 46, 224\u2013233 (1999).","journal-title":"Ann. Neurol."},{"key":"25310_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1212\/01.WNL.0000134555.59460.5D","volume":"63","author":"Y Shiga","year":"2004","unstructured":"Shiga, Y. et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 63, 443\u2013449 (2004).","journal-title":"Neurology"},{"key":"25310_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/35081095","volume":"411","author":"GP Saborio","year":"2001","unstructured":"Saborio, G. P., Permanne, B. & Soto, C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810\u2013813 (2001).","journal-title":"Nature"},{"key":"25310_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm.2294","volume":"17","author":"R Atarashi","year":"2011","unstructured":"Atarashi, R. et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat. Med. 17, 175\u2013178 (2011).","journal-title":"Nat. Med."},{"key":"25310_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(20)30477-4","volume":"20","author":"P Hermann","year":"2021","unstructured":"Hermann, P. et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 20, 235\u2013246 (2021).","journal-title":"Lancet Neurol."},{"key":"25310_CR7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1056\/NEJMoa1315200","volume":"371","author":"CD Orr\u00fa","year":"2014","unstructured":"Orr\u00fa, C. D. et al. A test for Creutzfeldt-Jakob disease using nasal brushings. N. Engl. J. Med. 371, 519\u2013529 (2014).","journal-title":"N. Engl. J. Med."},{"key":"25310_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10571-006-9370-z","volume":"26","author":"K Satoh","year":"2006","unstructured":"Satoh, K. et al. 14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan. Cell. Mol. Neurobiol. 26, 45\u201352 (2006).","journal-title":"Cell. Mol. Neurobiol."},{"key":"25310_CR9","doi-asserted-by":"publisher","first-page":"105504","DOI":"10.1016\/j.nbd.2021.105504","volume":"159","author":"TTT Dong","year":"2021","unstructured":"Dong, T. T. T. et al. Formalin RT-QuIC assay detects prion-seeding activity in formalin-fixed brain samples from sporadic Creutzfeldt-Jakob disease patients. Neurobiol. Dis. 159, 105504 (2021).","journal-title":"Neurobiol. Dis."},{"key":"25310_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/acn3.51000","volume":"7","author":"A Mammana","year":"2020","unstructured":"Mammana, A. et al. Detection of prions in skin punch biopsies of Creutzfeldt-Jakob disease patients. Ann. Clin. Transl. Neurol. 7, 559\u2013564 (2020).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"25310_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/neup.12717","volume":"41","author":"H Honda","year":"2021","unstructured":"Honda, H. et al. Abnormal prion protein deposits with high seeding activities in the skeletal muscle, femoral nerve, and scalp of an autopsied case of sporadic Creutzfeldt-Jakob disease. Neuropathology 41, 152\u2013158 (2021).","journal-title":"Neuropathology"},{"key":"25310_CR12","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3390\/pathogens10121642","volume":"10","author":"K Xiao","year":"2021","unstructured":"Xiao, K. et al. Validation and application of skin RT-QuIC to patients in China with probable CJD. Pathogens 10, 1642 (2021).","journal-title":"Pathogens"},{"key":"25310_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00401-023-02661-2","volume":"147","author":"W Zhang","year":"2024","unstructured":"Zhang, W. et al. Large-scale validation of skin prion seeding activity as a biomarker for diagnosis of prion diseases. Acta Neuropathol. 147, 17 (2024).","journal-title":"Acta Neuropathol."},{"key":"25310_CR14","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1001\/jamaneurol.2024.3458","volume":"81","author":"ZY Chen","year":"2024","unstructured":"Chen, Z. Y. et al. Multisite skin biopsies vs cerebrospinal fluid for prion seeding activity in the diagnosis of prion diseases. JAMA Neurol. 81, 1263\u20131273 (2024).","journal-title":"JAMA Neurol."},{"key":"25310_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/neup.12399","volume":"37","author":"Y Iwasaki","year":"2017","unstructured":"Iwasaki, Y. et al. An autopsy case of Creutzfeldt-Jakob disease with a prion protein gene codon 180 mutation presenting with pathological laughing and an exaggerated startle reaction. Neuropathology 37, 575\u2013581 (2017).","journal-title":"Neuropathology"},{"key":"25310_CR16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1440-1789.2010.01192.x","volume":"31","author":"Y Iwasaki","year":"2011","unstructured":"Iwasaki, Y. et al. An autopsied case of V180I Creutzfeldt-Jakob disease presenting with panencephalopathic-type pathology and a characteristic prion protein type. Neuropathology 31, 540\u2013548 (2011).","journal-title":"Neuropathology"},{"key":"25310_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/19336896.2017.1414130","volume":"12","author":"A Akagi","year":"2018","unstructured":"Akagi, A. et al. Pathological progression of genetic Creutzfeldt-Jakob disease with a PrP V180I mutation. Prion 12, 54\u201362 (2018).","journal-title":"Prion"},{"key":"25310_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/neup.12355","volume":"37","author":"Y Iwasaki","year":"2017","unstructured":"Iwasaki, Y. Creutzfeldt-Jakob disease. Neuropathology 37, 174\u2013188 (2017).","journal-title":"Neuropathology"},{"key":"25310_CR19","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/neup.12516","volume":"38","author":"Y Iwasaki","year":"2018","unstructured":"Iwasaki, Y. et al. Autopsy case of V180I genetic Creutzfeldt-Jakob disease presenting with early disease pathology. Neuropathology 38, 638\u2013645 (2018).","journal-title":"Neuropathology"},{"key":"25310_CR20","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.clineuro.2010.03.015","volume":"112","author":"S Kobayashi","year":"2010","unstructured":"Kobayashi, S. et al. Cortical propagation of Creutzfeldt-Jakob disease with codon 180 mutation. Clin. Neurol. Neurosurg. 112, 520\u2013523 (2010).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"25310_CR21","doi-asserted-by":"publisher","first-page":"e004968","DOI":"10.1136\/bmjopen-2014-004968","volume":"4","author":"T Qina","year":"2014","unstructured":"Qina, T. et al. Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene. BMJ Open 4, e004968 (2014).","journal-title":"BMJ Open"},{"key":"25310_CR22","doi-asserted-by":"publisher","first-page":"10655","DOI":"10.1038\/s41598-017-10922-w","volume":"7","author":"A Franceschini","year":"2017","unstructured":"Franceschini, A. et al. High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions. Sci. Rep. 7, 10655 (2017).","journal-title":"Sci. Rep."},{"key":"25310_CR23","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/jnnp-2021-328720","volume":"93","author":"K Kosami","year":"2022","unstructured":"Kosami, K. et al. Methionine homozygosity for PRNP polymorphism and susceptibility to human prion diseases. J Neurol Neurosurg Psychiatry. 93, 779\u2013784 (2022).","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"25310_CR24","doi-asserted-by":"publisher","first-page":"648743","DOI":"10.3389\/fnins.2021.648743","volume":"15","author":"S Abu-Rumeileh","year":"2021","unstructured":"Abu-Rumeileh, S. & Parchi, P. Cerebrospinal fluid and blood neurofilament light chain protein in prion disease and other rapidly progressive dementias: Current state of the art. Front Neurosci. 15, 648743 (2021).","journal-title":"Front Neurosci."},{"issue":"9","key":"25310_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-022-02891-7","volume":"59","author":"M Schmitz","year":"2022","unstructured":"Schmitz, M. et al. Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease. Mol. Neurobiol. 59(9), 1\u20139 (2022).","journal-title":"Mol. Neurobiol."},{"key":"25310_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/biom15010008","volume":"15","author":"M Shimamura","year":"2024","unstructured":"Shimamura, M. et al. Neurofilament light cain levels in serum and cerebrospinal fluid do not correlate with survival times in patients with prion disease. Biomolecules 15, 8 (2024).","journal-title":"Biomolecules"},{"key":"25310_CR27","doi-asserted-by":"publisher","first-page":"e0126930","DOI":"10.1371\/journal.pone.0126930","volume":"10","author":"H Takatsuki","year":"2015","unstructured":"Takatsuki, H. et al. Rapid and quantitative assay of amyloid-seeding activity in human brains affected with prion diseases. PLoS ONE 10, e0126930 (2015).","journal-title":"PLoS ONE"},{"key":"25310_CR28","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/brain\/awp191","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr, I. et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132, 2659\u20132668 (2009).","journal-title":"Brain"},{"key":"25310_CR29","unstructured":"CJD. National Creutzfeldt\u2013Jakob disease research and surveillance, sporadic CJS. 2023. https:\/\/www.cjd.ed.ac.uk\/sites\/default\/files\/criteria_0.pdf. Accessed Jan 2023."},{"key":"25310_CR30","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/labinvest.2009.68","volume":"90","author":"K Satoh","year":"2010","unstructured":"Satoh, K. et al. Establishment of a standard 14-3-3 protein assay of cerebrospinal fluid as a diagnostic tool for Creutzfeldt-Jakob disease. Lab. Invest. 90, 1637\u20131644 (2010).","journal-title":"Lab. Invest."},{"key":"25310_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000107082","volume":"24","author":"K Satoh","year":"2007","unstructured":"Satoh, K. et al. Total Tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease. Dement. Geriatr. Cogn. Disord. 24, 207\u2013212 (2007).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"25310_CR32","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12916-020-01608-8","volume":"18","author":"SM Vallabh","year":"2020","unstructured":"Vallabh, S. M. et al. Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease. BMC Med. 18, 140 (2020).","journal-title":"BMC Med."},{"key":"25310_CR33","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1212\/WNL.0b013e31821a4439","volume":"76","author":"P Vitali","year":"2011","unstructured":"Vitali, P. et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology 76, 1711\u20131719 (2011).","journal-title":"Neurology"},{"key":"25310_CR34","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1055\/s-0037-1608808","volume":"37","author":"AM Staffaroni","year":"2017","unstructured":"Staffaroni, A. M. et al. Neuroimaging in dementia. Semin. Neurol. 37, 510\u2013537 (2017).","journal-title":"Semin. Neurol."},{"key":"25310_CR35","unstructured":"World Health Organization. WHO global surveillance, diagnosis, and therapy of human transmissible spongiform encephalopathies: report of WHO consultation, Geneva, Switzerland, 9\u201311 February 1998. https:\/\/iris.who.int\/handle\/10665\/65516106656. Accessed 20 Jan 2021."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25310-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25310-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25310-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T01:01:51Z","timestamp":1764378111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25310-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25310"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25310-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Study approval 1\n                      : The experimental protocols were approved by the Ethics Committee of Nagasaki University Graduate School of Biomedical Sciences (Approval Nos. UMIN000038398, UMIN000016855, and UMIN000003301).\n                      Study approval 2\n                      : The research was conducted in accordance with the Declaration of Helsinki and the \u201cEthical Guidelines for Medical Research Involving Human Subjects\u201d issued by the Ministry of Health, Labor and Welfare. The ethics committee, Nagasaki University Graduate School of Biomedical Sciences. Consent was obtained from all authors for publication. All patients or family members of patients participating in this research have understood and agreed to the ethics committee documents for this research. Informed consent to participate was obtained from all the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"We obtained all authors\u2019 consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The research protocol received informed consent from all participants or their legal guardians, in accordance with ethical guidelines. Individual consent forms are archived by the corresponding author to uphold participant confidentiality. This study uses data devoid of all personal identifying information.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"We obtained all authors\u2019 consent for publication.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements from author and publisher"}}],"article-number":"41492"}}